Related Experiment Videos

Mutations in apbC (mrp) prevent function of the alternative pyrimidine biosynthetic pathway in Salmonella typhimurium

L Petersen1, D M Downs

  • 1Department of Bacteriology, University of Wisconsin--Madison, 53706, USA.

Journal of Bacteriology
|October 1, 1996
PubMed

Insights

The alternative pyrimidine biosynthetic pathway in Salmonella typhimurium synthesizes thiamine. A newly identified gene, apbC, is crucial for this process, acting in the conversion of aminoimidazole ribonucleotide to HMP.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • The alternative pyrimidine biosynthetic (APB) pathway synthesizes the HMP moiety of thiamine in Salmonella typhimurium.
  • This pathway operates independently of de novo purine biosynthesis.

Purpose of the Study:

  • To identify and characterize genes involved in the APB pathway.
  • To elucidate the function of the newly identified apbC gene in thiamine synthesis.

Main Methods:

  • Isolation and characterization of APB pathway mutants.
  • Genetic analysis of apbC mutations.
  • Sequence analysis of the apbC locus.

Main Results:

  • A predominant class of mutants (40%) were defective in a single locus, designated apbC.
  • apbC mutations block APB pathway function and cause thiamine auxotrophy.
  • Sequence analysis revealed apbC mutations are alleles of the mrp locus.

Conclusions:

  • ApbC is involved in the conversion of aminoimidazole ribonucleotide to HMP.
  • ApbC likely performs a redundant step in thiamine synthesis.
  • The mrp locus in S. typhimurium should be designated apbC due to its role in thiamine synthesis.

Related Concept Videos